Results

Total Results: 2,204 records

Showing results for "drugs".

141. Comparative Effectiveness of First and Second Generation Antipsychotics in the Adult Population | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antipsychotics-adults/research-protocol
     December 01, 2019 - New drugs for the treatment of schizophourenic patients. … Developing novel antipsychotic drugs: strategies and goals. … Curr Opin CPNS Invest Drugs 2000;2:25-39. Dawkins K, Lieberman JA, Lebowitz BD, et al. … Effectiveness of antipsychotic drugs in patients with chouronic Schizophrenia. … Comparative effectiveness of antipsychotic drugs.

142. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
     October 05, 2018 - Drugs Used for Osteoporosis Treatment and Prevention Drug class Drug name Delivery route Dosing … Interventions • Drugs FDA approved for osteoporosis treatment or prevention (bisphosphonates, denosumab

143. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - number of agents are currently available to treat osteoporosis, including the bisphosphonate class of drugs … Controlled clinical trials that report fracture outcomes for one or more of the drugs of interest will … In our search to identify clinical studies of drugs of interest to this review, we will use terms for … osteoporosis, osteopenia, low bone density, and the drugs listed in the key questions (as well as any … In our search for the key AE, we will use terms for the AE and each of the drugs of interest for this

144. Anxiety in Children | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/anxiety-children/research-2017
     January 01, 2020 - addition to anxiety, evaluate the effectiveness of the components of cognitive behavioral therapy, compare drugs … Data on head-to-head comparisons across drugs were sparse (only 2 RCTs; low SOE). … research is needed to evaluate components of CBT, effect modifiers of treatment, and long-term safety of drugs

145. Data Points #19: Medication Use in Medicare | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/medicare-medication-use/research
     December 01, 2019 - Care for chronic physical and psychiatric conditions often includes the use of multiple prescription drugs … Multiple medications and use of psychotropic drugs increases the possibility of adverse drug events. … the Medicare Part D program between 2005 and 2006, Medicare expenditures for outpatient prescription drugs

146. Management of Primary Headaches in Pregnancy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/headaches-pregnancy/research
     June 01, 2022 - The drugs and drug classes displayed in the visualization above are the only ones for which adequate … In other words, there were no conclusions for drugs and drug classes not listed and no conclusions for … However, the risks involved in using the same drugs for treatment of other conditions (e.g., seizures … We did not consider levels of various drugs in maternal serum/blood or in other fluids transmitted to … We found that the most complete resource with data about levels of the various drugs is the Drugs and

147. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists two topics for which (1) preliminary phase III data were available for drugs … Prescription drugs: abuse and addiction. [internet].

148. Autoimmune Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases
     November 01, 2024 - Sometimes doctors prescribe corticosteroids or other drugs that reduce your immune response. … Children Systematic Review Archived September 26, 2011 Disease-Modifying Antirheumatic Drugs

149. Autoimmune Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases?page=0
     November 01, 2024 - Sometimes doctors prescribe corticosteroids or other drugs that reduce your immune response. … Children Systematic Review Archived September 26, 2011 Disease-Modifying Antirheumatic Drugs

150. Eisenberg Center Series on Communication and Medical Decision Making | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/collections/eisenberg-center-meeting
     January 01, 2022 - proceedings of the scientific meetings are listed below: Communicating Harms and Benefits of Prescription Drugs … White Paper | Sep 30, 2006 Communicating Harms and Benefits of Prescription Drugs to Health Care

151. Allergy-Seasonal Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
     July 01, 2013 - Six classes of drugs and nasal saline are used to treat SAR. … • Corticosteroids are potent anti-inflammatory drugs. … conclusions generalize to other drugs in the same class is uncertain. … • We included FDA-approved drugs only. … effects of other drugs.

152. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - Pharmacologic agents include the bisphosphonate class of drugs, peptide hormones (parathyroid hormone … that had been rejected on the basis of drugs that were now included within the scope of the update … indicated for the treatment of osteoporosis (but not if the drugs were being used to treat cancer); … , and single drug versus single drug comparisons for drugs within the same class and across classes … • How was exposure to drugs/exercise ascertained?

153. Data Development for Patient Safety — A Pilot Study using Medicare Part B Drug Data | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/patient-safety-drug-data/abstract
     April 01, 2018 - As Medicare Part D records become available, the claims data will also incorporate the use of pharmaceuticals … structures that link relevant interventions, outcomes and patient characteristics for the study of pharmaceuticals … The analysis will exploit information available in Part B claims on drugs, to produce a framework that

154. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … They are lorcaserin (Lorgess ® , Arena Pharmaceuticals, Inc., San Diego, CA) and naltrexone HCl/bupropion … In May 2012, the FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 18-4 in favor of … Phentermine/topiramate is a controlled-release formulation of two separate FDA-approved drugs.

155. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
     January 01, 2011 - treatment might be severity dependent and should be defined by functional class Intervention(s): Newer drugs … failure, improved dyspnea, improved functional class, improved quality of life); side effects of various drugs

156. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
     September 01, 2019 - Newly approved drugs and those under review by the FDA are described in Section B (see Table 1) above … Few data are available on efficacy for these drugs; even less is known about how their effectiveness … and harms compared with that of existing drugs. … What has Changed New drugs: Additional clinical trials of three biosimilar drugs and a tsDMARD (an … Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.

157. Urinary-Incontinence-Treatment Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
     September 30, 2010 - Adverse events resulting from drugs. 2. … Adrenergic drugs for urinary incontinence in adults. … Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. … Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. … delirium/confusional state; urinary tract infection (symptomatic); atrophic urethritis/vaginitis; use of pharmaceuticals

158. Treatments for Adults with Schizophrenia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/schizophrenia-adult/research-protocol
     September 01, 2019 - Additionally, substance abuse (e.g., tobacco, alcohol, illicit drugs) may begin early on for patients … and in 2013 for 2 nd versus 2 nd generation drugs. … Consensus development conference on antipsychotic drugs and obesity and diabetes. … Drug Class Review of Atypical Antipsychotic Drugs; Update 3. … Drug Class Review: Second Generation Antipsychotic Drugs. Final Report - Update 4.

159. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetic-neuropathy/research-2017
     April 01, 2020 - However, oral drugs and spinal cord stimulation have substantial adverse effects. … For harms, all effective oral drugs had more than 9 percent dropouts due to adverse effects. … generally short term with unclear risk of bias, we could not draw conclusions for quality of life, all oral drugs

160. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
     March 10, 2010 - The lack of information about who is most likely to experience adverse affects from the drugs. … Nowhere in the medical literature are these drugs considered "chemotherapy". … After all, some women on all of the drugs got breast cancer. … We did not attempt to combine trials of different drugs. … Is there any literature about any of these drugs with women younger than 50?